Course Director:
Manju T. Beier, Pharm..D., FASCP
President, Geriatric Consultant Resources, LLC
Clinical Associate Professor, College of Pharmacy
University of Michigan, Ann Arbor, Michigan, USA
Upon completion of this program, the participant should be able to:
Compare and contrast the epidemiology, clinical presentation, and clinical course of dementia and delirium in the elderly.
List medications, medical disorders, and medical conditions that may produce or exacerbate psychotic and behavioral disturbances associated with delirium and dementia in the elderly patient.
Describe the types and etiology of noncognitive behavioral disturbances associated with dementia in elderly patients and identify target behaviors that are most likely to respond to drug therapy.
Outline a rational therapeutic approach for the management of the aforementioned behavioral disturbances in an elderly patient.
List nonpharmacologic strategies (such as, environmental manipulation) that can help alleviate behavioral disturbances associated with dementia in the elderly patient.
Discuss the efficacy, adverse effects, dosing, drug interactions, and monitoring parameters of antipsychotics, and the potential role of non-neuroleptic agents in the management of behavioral disturbances associated with dementia in the elderly.
Compare and contrast the side effect profile of high, intermediate and low potency neuroleptics, and discuss how these differences affect the choice of an agent.
Discuss how the newer "atypical" antipsychotics (clozapine, olanzapine, risperidone, quetiapine, and ziprasidone) differ from the "traditional" agents, and outline their role in the management of behavioral disturbances associated with dementia in the elderly.
Target audience
Geriatric health-care practitioners
Accreditation
At this time we are offering CE for pharmacists only. The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Initial Release Date: June 1998
Expiration Date: June 2001
New Release Date: September 2002
New Expiration Date: September 2005
This program (Program {INDIVIDUAL PROGRAM NUMBER #203-999-02-603-H01)} qualifies for 0.150 CEUs (1.50 contact hours) of continuing pharmaceutical education. CEUs will be awarded provided that the participant reviews this site and scores 70% or better on the post test that follows. To receive a statement of credit, please complete the examination and evaluation that follows this program. A statement will be awarded and mailed to you within 4-6 weeks.
The information provided in these programs is intended solely for the continuing educational needs of health-care practitioners. The medications discussed in these programs have Food and Drug Administration approval in the US. Individuals should not exclusively rely upon the information provided in these programs.
The continuing education programs are offered "as is" Geriatric Consultant Resources, LLC disclaims all warranties and representations, express or implied, with respect to the programs and the information contained therein, including without limitation any and all warranties of title, non infringement, merchantability, or fitness for any particular purpose. Without limiting the foregoing, Geriatric Consultant Resources LLC shall not be responsible for any inaccuracy or omission in the information contained in the programs, and shall have no liability whatsoever of any kind resulting from any claim or action arising out of the use of the programs.
